Fibrosis and cirrhosis reversibility - molecular mechanisms
Date
2008
Authors
Gieling, R.
Burt, A.
Mann, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Clinics in Liver Disease, 2008; 12(4):915-937
Statement of Responsibility
Roben G. Gieling, Alastair D. Burt, Derek A. Mann
Conference Name
Abstract
The concept that liver fibrosis is a dynamic process with potential for regression as well as progression has emerged in parallel with clinical evidence for remodeling of fibrotic extracellular matrix in patients who can be effectively treated for their underlying cause of liver disease. This article reviews recent discoveries relating to the cellular and molecular mechanisms that regulate fibrosis regression, with emphasis on studies that have used experimental in vivo models of liver disease. Apoptosis of hepatic myofibroblasts is discussed. The functions played by transcription factors, receptor-ligand interactions, and cell-matrix interactions as regulators of the lifespan of hepatic myofibroblasts are considered, as are the therapeutic opportunities for modulating these functions. Growth factors, proteolytic enzymes, and their inhibitors are discussed in detail
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2008 Elsevier Inc. All rights reserved.